This dosage sensitivity suggests the ATXN2 gene as a good candidate for detailed analysis of genetic variation, both common and rare, in a number of human phenotypes as diverse as obesity, motor hyperactivity, anxiety, and depression. This evidence concerns the gene ATXN2 and depressive symptom measurement.